Stock listing
Pharmagreen Biotech Inc.
Selected listing: PHBI · OTC · USD · US
Pharmagreen Biotech Inc. (OTC:PHBI), Commercial Services. Latest release Oct 10, 2024: Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential…
- Ticker
- OTC:PHBI
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- OTC
- Currency
- USD
About Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. is a public company traded under the ticker PHBI in the American market. Pharmagreen focuses on biotechnological advancements, although specific details about its operations and offerings are not provided.
Latest news from Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project
October 9, 2024
Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress
September 18, 2024
PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations
January 23, 2024
PHBI – Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation
September 4, 2023
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product
February 8, 2023
Research Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. company profile
View the public company page for Pharmagreen Biotech Inc. on 6ix.
Pharmagreen Biotech Inc. news
Read company news and market updates connected to Pharmagreen Biotech Inc..
Pharmagreen Biotech Inc. investor events
Find investor webinars, events, and replay context for Pharmagreen Biotech Inc..